Drug Profile
Doxorubicin liposomal - LipoCure
Alternative Names: LC 100Latest Information Update: 28 May 2019
Price :
$50
*
At a glance
- Originator LipoCure
- Class Anthracyclines; Antineoplastics; Antivirals; Cytostatic antibiotics; Doxorubicins; Hepatoprotectants; Small molecules
- Mechanism of Action Type II DNA topoisomerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Breast cancer; Ovarian cancer
Most Recent Events
- 28 May 2019 No recent reports of development identified for phase-0 development in Breast-cancer in Israel (IV)
- 28 May 2019 No recent reports of development identified for phase-0 development in Ovarian-cancer in Israel (IV)
- 18 Apr 2016 Phase-0 for Breast cancer in Israel (IV) before April 2016